This inventor holds 1 USPTO granted patent and 2 published patent applications and 1 EPO patent. Top assignee: Profectus Biosciences, Inc.. Active years: 2014.
Company Filing History:
Years Active: 2014
Title: The Innovative Contributions of Charles E. Ducker
Introduction
Charles E. Ducker is a notable inventor based in York, PA (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds aimed at treating various serious health conditions. His work is characterized by a commitment to innovation and a focus on improving patient outcomes.
Latest Patents
Ducker holds a patent for "Inhibitors of NF-κB." This invention relates to compounds of specific formulae and pharmaceutically acceptable salts that are intended for the treatment of cancer, inflammation, auto-immune diseases, diabetes and its complications, infections, cardiovascular diseases, and ischemia-reperfusion injuries. His patent portfolio includes 1 patent that reflects his dedication to advancing medical science.
Career Highlights
Charles E. Ducker is currently associated with Profectus Biosciences, Inc., where he continues to work on innovative solutions in the pharmaceutical industry. His career is marked by a focus on developing therapies that address critical health challenges faced by patients today.
Collaborations
Ducker has collaborated with notable colleagues such as Jie Zhang and Drago Robert Sliskovic. These partnerships have contributed to the advancement of his research and the successful development of his patented inventions.
Conclusion
Charles E. Ducker's work exemplifies the spirit of innovation in the pharmaceutical field. His contributions through his patent and collaborations highlight the importance of research and development in addressing complex health issues.